Atogepant (Qulipta) is an oral calcitonin gene-related peptide (CGRP) antagonist used as a second-line preventive therapy manage one type of chronic headache. For which type of headache is it primarily indicated?

A. Chronic migraine
B. Sinus headache
C. Cluster headache
D. Tension-type headache